1. Introduction
===============

Stems or fruits of plants in the Schisandraceae family are used widely in China as tonic and astringent agents for the treatment of rheumatic arthritis, traumatic injury, and related diseases \[[@B1-molecules-18-02297]\]. Schisandraceae plants are rich in lignans, especially dibenzocyclooctadiene lignans, which show beneficial pharmacological effects, including anti-HIV, antitumor-promoting, calcium antagonistic, and anti-lipid peroxidative actions \[[@B2-molecules-18-02297],[@B3-molecules-18-02297],[@B4-molecules-18-02297],[@B5-molecules-18-02297],[@B6-molecules-18-02297],[@B7-molecules-18-02297],[@B8-molecules-18-02297],[@B9-molecules-18-02297],[@B10-molecules-18-02297],[@B11-molecules-18-02297],[@B12-molecules-18-02297],[@B13-molecules-18-02297]\].

In our previous study, we reported four new dibenzocyclooctadiene lignans from the stems of *Schisandra* *neglecta*, which is indigenous to the Tibet Autonomous Region of China \[[@B14-molecules-18-02297],[@B15-molecules-18-02297]\]. Our further investigation of the same plant has now led to the isolation and identification of two new dibenzocyclooctadiene lignans, named neglschisandrins E (**1**) and F (**2**) ([Figure 1](#molecules-18-02297-f001){ref-type="fig"}), together with thirteen known lignans, 6-*O*-benzoylgomisin O (**3**) \[[@B16-molecules-18-02297]\], (+)-γ-rubschisandrin (**4**) \[[@B17-molecules-18-02297]\], rubschisantherin (**5**) \[[@B17-molecules-18-02297]\], benzoylisogomisin O (**6**) \[[@B18-molecules-18-02297]\], schisandrin A (**7**) \[[@B19-molecules-18-02297]\], schisanhenol (**8**) \[[@B20-molecules-18-02297]\], angeloylgomisin H (**9**) \[[@B21-molecules-18-02297]\], gomisin H (**10**) \[[@B21-molecules-18-02297]\], tigloylgomisin H (**11**) \[[@B21-molecules-18-02297]\], benzoylgomisin H (**12**) \[[@B21-molecules-18-02297]\], schisandrin (**13**) \[[@B22-molecules-18-02297]\], gomisin B (**14**) \[[@B23-molecules-18-02297]\], and angeloyl-(+)-gomisin K~3~ (**15**) \[[@B24-molecules-18-02297]\]. This paper reports the isolation and structural elucidation of these compounds as well as their *in vitro* cytotoxicity against human lung carcinoma A549 and human colorectal carcinoma HCT-8 cell lines.

![Structures of Compounds **1**--**2**.](molecules-18-02297-g001){#molecules-18-02297-f001}

2. Results and Discussion
=========================

A 95% alcoholic extract prepared from stems of *Schisandra neglecta* was partitioned between diethyl ether and water. The diethyl ether extract was subjected to silica gel column chromatography (CC), preparative TLC, and semi-preparative reversed phase HPLC to give the two new and thirteen known dibenzocyclooctadiene lignans named above.

Compound **1**, obtained as amorphous powder, had the molecular formula C~22~H~26~O~6~ based on HR-ESI-MS (*m/z* 387.1810 \[*M*+H\]^+^). The UV and NMR spectra indicated that **1** was a dibenzocyclooctadiene lignan \[[@B25-molecules-18-02297]\]. The ^1^H-NMR spectrum of **1** ([Table 1](#molecules-18-02297-t001){ref-type="table"}) showed signals due to two secondary methyl groups (*δ*~H~ 0.97, 0.73, each 3H, *d*, *J* = 7.1 Hz), assignable to the *cis*-oriented Me-7 and Me-8, respectively \[[@B26-molecules-18-02297]\]. The presence of four benzylic methylene signals (*δ*~H~ 2.25, 1H, *dd*, *J* = 13.0, 9.6; 2.01 Hz, 1H, *d*, *J* = 13.0 Hz; 2.55, 1H, *dd*, *J* = 13.6, 7.4; 2.45 Hz, 1H, *dd*, *J* = 13.6, 1.5 Hz) indicated that C-6 and C-9 were unsubstituted. The ^1^H-NMR spectrum also showed signals for two aromatic protons (*δ*~H~ 6.63, 6.49 each 1H, s), assignable to CH-4 and CH-11, respectively. Three methoxy groups \[*δ*~H~ 3.50, 3.79 and 3.93, each 3H, s) and a methylenedioxy (--OCH~2~O--) moiety (*δ*~H~ 5.96, 5.95, each 1H, *d*, *J* = 1.3 Hz\] were also observed as substituents on the aromatic rings. The proton signal at *δ*~H~ 5.68 (br s) showed no correlations in the HMQC spectrum, and was assigned as an hydroxyl on the aromatic ring. This assignment was supported by an IR band at 3447 cm^−1^ \[[@B27-molecules-18-02297]\].
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^1^H- (400 MHz) and ^13^C- (100 MHz) NMR data (measured in *CDCl~3~*) for compounds **1** and **2** (*δ* in ppm, *J* in Hz).

                 1             2                                           
  -------------- ------------- ----------------------------- ------------- ------------------------------
  Position       *δ*~C~        *δ*~H~                        *δ*~C~        *δ*~H~
                                                             S             
  1              150.3 (*s*)   \-                            152.3 (*s*)   \-
  2              137.4 (*s*)   \-                            139.9 (*s*)   \-
  3              148.8 (*s*)   \-                            152.6 (*s*)   \-
  4              110.2 (*d*)   6.63 (*s*)                    106.3 (*d*)   6.38 (*s*)
  5              140.3 (*s*)   \-                            136.5 (*s*)   \-
  6              35.1 (*t*)    2.25 (*dd*, *J* = 9.6,13.0)   125.3 (*t*)   6.20 (*s*)
                               2.01 (*d*, *J* = 13.0)                      \-
  7              40.9 (*d*)    1.79 (*m*)                    142.2 (*s*)   \-
  8              33.8 (*d*)    1.88 (*m*)                    34.2 (*d*)    2.79 (*m*)
  9              38.9 (*t*)    2.55 (*dd*, *J* = 13.6,7.4)   42.9 (*t*)    3.10 (*dd*, *J* = 9,15.1)
                               2.45 (*dd*, *J* = 13.6,1.5)                 2.38 (*dd*, *J* = 10.0,15.1)
  10             132.7 (*s*)   \-                            135.3 (*s*)   \-
  11             106.2 (*d*)   6.49 (*s*)                    111.5 (*d*)   6.57 (*s*)
  12             147.7 (*s*)   \-                            151.6 (*s*)   \-
  13             135.1 (*s*)   \-                            139.3 (*s*)   \-
  14             141.3 (*s*)   \-                            142.5 (*s*)   \-
  15             122.5 (*s*)   \-                            124.1 (*s*)   \-
  16             121.3 (*s*)   \-                            122.1 (*s*)   \-
  17             21.8 (*q*)    0.97 (*d*, *J* = 7.1)         18.9 (*q*)    1.63 (*s*)
  18             12.4 (*q*)    0.73 (*d*, *J* = 7.1)         19.4 (*q*)    1.03 (*d*, *J* = 6.9)
  *M*eO-C (1)    60.1 (*q*)    3.50 (*s*)                    60.7 (*q*)    3.61 (*s*)
  *M*eO-C (2)    61.0 (*q*)    3.93 (*s*)                    60.8 (*q*)    3.84 (*s*)
  *M*eO-C (3)    \-            \-                            55.9 (*q*)    3.83 (*s*)
  *M*eO-C (12)   \-            \-                            55.9 (*q*)    3.88 (*s*)
  *M*eO-C (13)   \-            \-                            60.7 (*q*)    3.80 (*s*)
  *M*eO-C (14)   59.7 (*q*)    3.79 (*s*)                    \-            \-
  HO-C (3)                     5.68 (*brs*)                                \-
  OCH~2~O        100.8 (*t*)   5.96, 5.95 (*d*, *J* = 1.3)   \-            \-
  Ang:1\'        \-            \-                            165.2 (*s*)   \-
  2\'            \-            \-                            127.8 (*s*)   \-
  3\'            \-            \-                            136.8 (*d*)   5.86 (*m*)
  4\'            \-            \-                            15.3 (*q*)    1.78 (*s*)
  5\'            \-            \-                            20.3 (*q*)    1.72 (*d*, *J* = 7.1)

HMBC correlations of CH-11 (*δ*~H~ 6.49) and methylenedioxy (*δ*~H~ 5.96, 5.95) protons with aromatic carbons at *δ*~C~ 147.7, 135.1 indicated that the methylenedioxy group was located at C-12 and C-13. Correlations of the CH-4 proton (*δ*~H~ 6.63) with carbons at *δ*~C~ 148.8 (C-3) and 137.4 (C-2) and of the hydroxyl proton at *δ*~H~ 5.68 with carbons at *δ*~C~ 110.2 (C-4), 148.8 (C-3) and 137.4 (C-2), indicated that the hydroxyl was located at C-3. Thus, the three methoxy groups were located at C-1, C-2, and C-14, based on HMBC correlations of the protons at *δ*~H~ 3.79, 3.93 and 3.50 with aromatic carbons at *δ*~C~ 141.3 (C-14), 137.4 (C-2) and 150.3 (C-1), respectively.

The circular dichroism (CD) spectrum of **1** showed a negative Cotton effect at 216 nm and a positive *Cotton* effect at 254 nm, which indicated an *R*-biphenyl configuration in **1** \[[@B28-molecules-18-02297]\]. NOESY correlations between CH-11/Me-18, CH-4/CH-6α and CH-11/CH-9β indicated a twist-boat-chair (TBC) conformation for the cyclooctadiene ring \[[@B29-molecules-18-02297]\] ([Figure 2](#molecules-18-02297-f002){ref-type="fig"}). The substituent positions and stereochemical assignments in the cyclooctadiene ring of **1** were further supported by NOESY correlations of MeO-1/MeO-14, Me-17/Me-18, CH-6β/Me-18 and CH-4/CH-7. Thus, the structure of **1** was determined as that shown in [Figure 1](#molecules-18-02297-f001){ref-type="fig"}. Compound **1** and (−)-gomisin L~2~ have the same planar structure, but different stereochemistry \[[@B30-molecules-18-02297]\].

![Key HMBC (→) and NOESY (↔) Correlations of **1**.](molecules-18-02297-g002){#molecules-18-02297-f002}

Compound **2**, obtained as colorless powder, has the molecular formula C~28~H~34~O~7~ according to HR-ESI-MS (*m/z* 505.2187 \[*M*+Na\]^+^). Its IR, UV, CD and NMR data indicated that **2** is a also a dibenzocyclooctadiene lignan. The ^1^H-NMR spectrum of **2** ([Table 1](#molecules-18-02297-t001){ref-type="table"}) showed the presence of five methoxy groups at *δ*~H~ 3.61, 3.80, 3.83, 3.84 and 3.88 (each 3H, s), and an angeloyl group at *δ*~H~ 5.86 (1H, m), 1.78 (3H, s), 1.72 (3H, *d*, *J* = 7.1 Hz) on aromatic rings \[[@B24-molecules-18-02297]\].

The following proton-carbon HMBC correlations were observed: CH-4 (*δ*~H~ 6.38) with C-3 (*δ*~C~ 152.6) and C-2 (*δ*~C~ 139.9), CH-11 (*δ*~H~ 6.57) with C-12 (*δ*~C~ 151.6), C-13 (*δ*~C~ 139.3) and C-14 (*δ*~C~ 142.5), and the five methoxy signals at *δ*~H~ 3.61, 3.84, 3.83, 3.88 and 3.80 with aromatic carbon signals at *δ*~C~ 152.3 (C-1), 139.9 (C-2), 152.6 (C-3), 151.6 (C-12) and 139.3 (C-13), respectively. These correlations indicated that the five methoxy groups were attached to C-1, C-2, C-3, C-12, and C-13, and the angeloyl group was located at C-14 ([Figure 3](#molecules-18-02297-f003){ref-type="fig"}).

![Key HMBC correlations of **2**.](molecules-18-02297-g003){#molecules-18-02297-f003}

Furthermore, the ^1^H-NMR spectrum of **2** showed a proton signal at *δ*~H~ 6.20 (1H, *s*) and the ^13^C-NMR spectrum showed a quaternary olefinic carbon at *δ*~C~ 142.2 and a methine olefinic carbon at *δ*~C~ 125.3, suggesting the formation of a double bond. A singlet methyl signal at *δ*~H~ 1.63 (3H, *s*, Me-17) in the ^1^H-NMR spectrum indicated that the double bond was located between C-6 and C-7 and was substituted with a methyl group. HMBC correlations of *δ*~H~ 6.38 (CH-4) with *δ*~C~ 125.3 (C-6), *δ*~H~ 6.20 (CH-6) with *δ*~C~ 136.5 (C-5), 122.1 (C-16) and 18.9 (C-17), *δ*~H~1.63 (Me-17) with *δ*~C~ 142.2 (C-7) and 34.2 (C-8), *δ*~H~ 2.38 and 3.10 (CH~2~-9) with *δ*~C~ 142.2 (C-7) confirmed the substructure.

The CD spectrum of **2** had a negative *Cotton* effect at 219 nm and a positive *Cotton* effect at 251 nm, indicating that **2** has an *R*-biphenyl configuration. The NOESY correlations between CH-4/CH-6, CH-6/Me-17, and CH-11/CH-9β, CH-9α/CH-8, CH-11/MeO-12, CH-9β/Me-18, and Me-17/Me-18 fully supported the assigned structure and stereochemistry ([Figure 4](#molecules-18-02297-f004){ref-type="fig"}). Compound **2** has an endocylic double bond rather than the exocyclic double bond found in the previously reported neglschisandrin B \[[@B14-molecules-18-02297]\].

![Key NOESY correlations of **2**.](molecules-18-02297-g004){#molecules-18-02297-f004}

The lignans were evaluated *in vitro* for cytotoxicity against human lung carcinoma A549 and human colorectal carcinoma HCT-8 cell lines employing a MTT-assay with paclitaxel as the positive control ([Table 2](#molecules-18-02297-t002){ref-type="table"}). Five lignans exhibited moderate cytotoxicity, while the remaining lignans showed no activity. Against HCT-8, compounds **3** and **6** showed moderate cytotoxicity (EC~50~ 9.58 and 7.33 μg/mL, respectively); compounds **2** and **4** exhibited marginal cytotoxicity (EC~50~ 13.8 and 12.6 μg/mL, respectively), and compound **5** showed weak cytotoxicity (EC~50~ 19.6 μg/mL). Against A549, compounds **2**--**4** exhibited marginal cytotoxicity with EC~50~ values ranging from 11.8 to 15.0 μg/mL.

molecules-18-02297-t002_Table 2
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Cytotoxicity data of lignans from *Schisandra neglecta.*

  Compound     Cytotoxicity (EC~50~, μg/mL)   
  ------------ ------------------------------ ---------
  **2**        13.8                           11.8
  **3**        9.58                           13.8
  **4**        12.6                           15.09
  **5**        19.8                           NA ^a^
  **6**        7.33                           NA ^a^
  Paclitaxel   0.21                           \<0.005

^a^ NA (not active)\--test compound (20 μg/mL) did not reach 50% inhibition.

3. Experimental
===============

3.1. General
------------

Optical rotations: *P-1020* digital spectropolarimeter (JASCO) with MeOH as solvent. UV spectra: *Hitachi* *U-3010* spectrophotometer in MeOH; λ~max~ (log *ε*) in nm. ^1^H-, ^13^C-, 2D-NMR spectra: *Bruker DRX400* (400 MHz for ^1^H, 100 MHz for ^13^C) spectrometer in *CDCl~3~*; *δ* in ppm rel. to Me~4~Si as internal references. *J* in Hz. ESI mass: *Bio TOF Q* spectrometer; in *m/z* (rel. %). HR-ESI-MS: *Bruker Daltonics BioToF-ШQ* mass spectrometer in positive-ion mode (Bremen, Germany). IR spectra: *Avatar Thermo Nicolet* *360-ESP* spectrophotometer. TLC was performed on silica gel plates GF~254~ (Yantai Institute of Chemical Technology, Yantai, China). The TLC spots were visualized by UV light (254 nm) and sprayed with 10% H~2~SO~4~, followed by heating. Column chromatography (CC) was carried out on silica gel (200--300 mesh or 300--400 mesh Qingdao Marine Chemical Factory, Qingdao, China). Semi-prep HPLC was carried out on an octadecylsilane column (*RP-18*, 250 × 10 mm, 10 μm, YMC, detector: *Amersham UV-900*) with a flow rate of 3.0 mL/min.

3.2. Plant Material
-------------------

Stems of *Schisandra neglecta* were collected in Lin-zhi County, Tibet Autonomous Region, People's Republic of China in September of 2004, and identified by Professor Hong-ping Deng, School of Life Sciences, Southwest University. A voucher specimen (MC-LZ-040901) is deposited in the Herbarium of Medicinal Plant, School of Life Sciences, Southwest University, Chongqing, China.

3.3. Extraction and Isolation
-----------------------------

Powdered air-dried stems (5.0 kg) of *Schisandra neglecta* were extracted exhaustively with 95% EtOH (5 × 10 L, each three days) at room temperature. The alcoholic extract was evaporated *in vacuo* to yield a semisolid (430 g), which was suspended in water (1,000 mL) and extracted five times with diethyl ether. The organic solution was concentrated to yield 112 g of residue, which was subjected to silica gel CC eluted with petroleum ether/acetone mixtures of increasing polarity (99:1 to 3:7) to obtain ten fractions. Fraction 3 (8.3 g), eluted with petroleum ether--acetone (95:5), gave **7** (1.2 g), and then was further chromatographed with silica gel CC eluting with petroleum ether/CHCl~3~ (9:2) to obtain six subfractions. Subfraction 3--3 (1.3 g) was subjected to preparative TLC with petroleum ether/CHCl~3~ (1:1) to yield **4** (14 mg). Fraction 4 (7.4 g), eluted with petroleum ether/acetone (9:1), was subjected to CC with petroleum ether/EtOAc (15:1\~4:1) to obtain eight subfractions. Subfraction 4--3 (0.5 g) was purified by preparative HPLC with MeOH/H~2~O (70:30) to yield **5** (4 mg, RT 25.3 min) and **6** (10 mg, RT 31.1 min). Subfraction 4--4 (0.7 g) was subjected to preparative TLC with petroleum ether/CHCl~3~ (1:1) to yield **3** (17 mg). Subfraction 4--5 (0.3 g) was purified by semi-preparative HPLC with MeOH-H~2~O (70:30) to yield **1** (2 mg, RT 33.4 min). Subfraction 4--6 (3.2 g) was subjected to silica gel CC with petroleum ether-EtOAc (5:1) to yield **8** (2.3 g). Fraction 5 (6.7 g) eluted with petroleum ether-acetone (8:2) was subjected to silica gel CC with petroleum ether/EtOAc (10:2--5:2). Subfraction 5--2 (0.6 g) was purified by semi-preparative HPLC with MeOH/H~2~O (75:25) to yield **9** (32 mg, RT 37.5) and **15** (46 mg, RT 40.2). Subfraction 5--3 (1.7 g) was subjected to silica gel CC with petroleum ether/EtOAc (9:2), then purified by semi-preparative HPLC with MeOH/H~2~O (64:36--80:20) to yield **10** (4 mg, RT 25.6 min), **11** (10 mg, RT, 28.7 min), and **12** (43 mg, RT 37.9 min), Subfraction 5--5 (0.9 g) was subjected to silica gel CC with petroleum ether/CHCl~3~ (5:6), and further purified by semi-preparative HPLC with MeOH/H~2~O (7:3) to yield **13** (24 mg, RT 40.3 min) and **14** (19 mg, RT 44.5 min). Fraction 6 (5.2 g) eluted with petroleum ether-acetone (7:3) was subjected to silica gel CC with petroleum ether/EtOAc (10:3). Subfraction 6--3 (0.7 g) was purified by semi-preparative HPLC with MeOH-H~2~O (75:25 to 85:15) to yield **2** (10 mg, RT 24. 7 min).

*6R,7S,R-biar-\[5,6,7,8-Tetrahydro-1,2,13-trimethoxy-6,7-dimethyl-benzo-\[3\',4\'\]cycloocta\[1\',2\':4,5\]-benzo\[1,2-d\]\[1,3\]dioxol-3-ol* (neglschisandrin E, **1**). White amorphous powder; \[α\]^22^~D~ +26.9° (c = 0.26, MeOH). UV (MeOH): 216 (4.67), 250 (4.22), 280 (3.97). CD (c = 0.08, MeOH), \[θ\]^15^ (nm): −28275 (216), +28636 (254). IR (KBr): 3447, 2925, 1615, 1585, 1476, 737. ^1^H-NMR and ^13^C-NMR: see [Table 1](#molecules-18-02297-t001){ref-type="table"}. HR-ESI-MS: found 387.1810 (\[M+H\]^+^, C~22~H~27~O~6~^+^, calc. 387.1808).

*5Z,7R,R-biar-7,8-Dihydro-1,2,3,10,11-pentamethoxy-13-(2Z)-methylbut-2-enoyl-6,7-dimethyl-dibenzo\[a,c\]cycloocten-5(6H)-one* (neglschisandrin F, **2**). White amorphous powder; \[α\]^22^~D~ +16.9° (c = 0.31, MeOH). UV (MeOH): 216 (4.78), 250 (4.37), 279 (3.97). CD (c = 0.052, MeOH), \[θ\]^15^ (nm): −295132 (219), +155445 (251). IR (KBr): 3404, 2936, 1737, 1636, 1591, 1488, 734. ^1^H-NMR and ^13^C-NMR: see [Table 1](#molecules-18-02297-t001){ref-type="table"}. HR-ESI-MS: found 505.2187 (\[M+Na\]^+^, C~28~H~34~NaO~7~^+^, calc. 505.2197).

3.4. Cytotoxicity Assay
-----------------------

Freshly trypsinized cell suspensions were seeded in 96-well microtiter plates at densities of 5,000--10,000 cells per well with compounds added from DMSO-diluted stock. After three days in culture, attached cells were incubated with cold 10% trichloroacetic acid (MTT, 0.5 mg/mL, 2 h) and subsequently solubilized in DMSO, and the isolates were tested against A549 and HCT-8 cancer cell lines using established colorimetric MTT assay protocols \[[@B31-molecules-18-02297]\]. Paclitaxel was used as a positive control. All stock cultures were grown in T-25 flasks. The mean EC~50~ is the concentration of agent that reduces cell growth by 50% under the experimental conditions and is the average from at least three independent determinations that were reproducible and statistically significant. The absorbance was measured at 550 nm using a microplate reader.

4. Conclusions
==============

Two new lignans, neglschisandrins E and F (**1** and **2**, respectively), and thirteen known lignans were isolated from stems of *Schisandra neglecta*. Their structures and stereochemistries were established by means of NMR and ESI-MS analyses, including 2D-NMR techniques. The isolates were evaluated for *in vitro* cytotoxic activity. Compounds **2**--**6** showed cytotoxicity against the human HCT-8 colorectal carcinoma cell line with EC~50~ values of 7.33\~19.8 μg/mL, while compounds **2**--**4** also exhibited cytotoxicity against the human A549 lung carcinoma cell line with EC~50~ values of 11.8\~15.0 μg/mL, respectively. Since other dibenzocyclooctadiene lignans in the genus *Schisandra* exhibit proven antitumor activities \[[@B32-molecules-18-02297]\], further research to identify related potent cytotoxic compounds or explore detailed structure-activity relationships is merited.
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